APA (7th ed.) Citation

Yamamoto, S., Iihara, H., Uozumi, R., Kawazoe, H., Tanaka, K., Fujita, Y., . . . Inui, N. (2021, July). Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: Integrated study of three prospective multicenter phase II trials. BMC Cancer.

Chicago Style (17th ed.) Citation

Yamamoto, Senri, et al. "Efficacy and Safety of 5 mg Olanzapine for Nausea and Vomiting Management in Cancer Patients Receiving Carboplatin: Integrated Study of Three Prospective Multicenter Phase II Trials." BMC Cancer Jul. 2021.

MLA (9th ed.) Citation

Yamamoto, Senri, et al. "Efficacy and Safety of 5 mg Olanzapine for Nausea and Vomiting Management in Cancer Patients Receiving Carboplatin: Integrated Study of Three Prospective Multicenter Phase II Trials." BMC Cancer, Jul. 2021.